Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapy
Saunders, Mark P
Price, Gareth J
Renehan, Andrew G
van Herk, Marcel
Vasquez Osorio, Eliana
AffiliationDepartment of Clinical Oncology, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
MetadataShow full item record
AbstractBackground and purpose: Patients with rectal cancer could avoid major surgery if they achieve clinical complete response (cCR) post neoadjuvant treatment. Therefore, prediction of treatment outcomes before treatment has become necessary to select the best neo-adjuvant treatment option. This study investigates clinical and radiomics variables' ability to predict cCR in patients pre chemoradiotherapy. Materials and methods: Using the OnCoRe database, we recruited a matched cohort of 304 patients (152 with cCR; 152 without cCR) deriving training (N = 200) and validation (N = 104) sets. We collected pre-treatment MR (magnetic resonance) images, demographics and blood parameters (haemoglobin, neutrophil, lymphocyte, alkaline phosphate and albumin). We segmented the gross tumour volume on T2 Weighted MR Images and extracted 1430 stable radiomics features per patient. We used principal component analysis (PCA) and receiver operating characteristic area under the curve (ROC AUC) to reduce dimensionality and evaluate the models produced. Results: Using Logistic regression analysis, PCA-derived combined model (radiomics plus clinical variables) gave a ROC AUC of 0.76 (95% CI: 0.69-0.83) in the training set and 0.68 (95% CI 0.57-0.79) in the validation set. The clinical only model achieved an AUC of 0.73 (95% CI 0.66-0.80) and 0.62 (95% CI 0.51-0.74) in the training and validation set, respectively. The radiomics model had an AUC of 0.68 (95% CI 0.61-0.75) and 0.66 (95% CI 0.56-0.77) in the training and validation sets. Conclusion: The predictive characteristics of both clinical and radiomics variables for clinical complete response remain modest but radiomics predictability is improved with addition of clinical variables.
CitationMbanu P, Saunders MP, Mistry H, Mercer J, Malcomson L, Yousif S, et al. Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapy. Physics and imaging in radiation oncology. 2022 Jul;23:48-53. PubMed PMID: 35800297. Pubmed Central PMCID: PMC9253904. Epub 2022/07/09. eng.
JournalPhysics and Imaging in Radiation Oncology
- Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
- Authors: Cui Y, Yang X, Shi Z, Yang Z, Du X, Zhao Z, Cheng X
- Issue date: 2019 Mar
- [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
- Authors: Zhang XY, Zhu HT, Li XT, Li YJ, Li ZW, Wang WH, Wu AW, Sun YS, Zhang L
- Issue date: 2022 Mar 25
- Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
- Authors: Li ZY, Wang XD, Li M, Liu XJ, Ye Z, Song B, Yuan F, Yuan Y, Xia CC, Zhang X, Li Q
- Issue date: 2020 May 21
- Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation.
- Authors: Cusumano D, Boldrini L, Yadav P, Yu G, Musurunu B, Chiloiro G, Piras A, Lenkowicz J, Placidi L, Romano A, De Luca V, Votta C, Barbaro B, Gambacorta MA, Bassetti MF, Yang Y, Indovina L, Valentini V
- Issue date: 2021 Apr
- Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study.
- Authors: Petresc B, Lebovici A, Caraiani C, Feier DS, Graur F, Buruian MM
- Issue date: 2020 Jul 14